Skip to main content
. 2022 Dec 6;2022:3618090. doi: 10.1155/2022/3618090

Figure 3.

Figure 3

Symptom severity (none/mild vs. severe) as defined by the PBC-40 questionnaire domains, according to allopregnanolone levels (ng/ml). (a) Cognitive; (b) emotional; (c) itch; (d) fatigue; (e) social; (f) general symptoms.